Gynecological pathology and cytopathology / Pathologie et cytopathologie gynécologique
Pierre Vassilakos
MD, pathologist
Former Director of the Center for Cytology, the Swiss School of Cytology, the Geneva Tumor Registry and
the Division of Gynecological Pathology, Department of Health and University Hospitals, Geneva, Switzerland
Former lecturer at the Faculty
of Medicine, University of Geneva
Responsible for Gynecological Pathology and Cytopathology at the Geneva Foundation for Medical Education
and Research
Pierre Vassilakos, MD, is former Director of the Center for Cytology, the Swiss School of Cytology, the Geneva Tumor Registry and the
Division of Gynecological Pathology, Department of Health and University Hospitals, Geneva, Switzerland.
As Lecturer of the Geneva Medical
School he was teaching residents and medical students and supervised medical theses.
Author of a book and more than 100 publications and
coprincipal investigator for the Department of Obstetrics and Gynecology, Dr. Vassilakos is often invited for lectures in national and
international meetings and is frequently contacted by the media regarding cervical cancer screening.
The focus of his studies has been the
epidemiology and natural history of cervical cancer as well the introduction of new technologies in cervical cancer screening in developed and
developing countries.
Dr Vassilakos is currently consultant Pathologist. He is also an investigator in clinical trials and in charge of
training and research in Gynecological Pathology and Cytopathology at the Geneva Foundation for Medical Education and Research.
Online publications indexed in PubMed
- Petignat P, Faltin D, Goffin F, Billieux M, Stucki D, Sporri S, Vassilakos P. Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma. Cancer [Internet]. 2005 Jun 25 [cited 2009 Apr 26];105(3):126-132. Available from: http://www3.interscience.wiley.com/cgi-bin/fulltext/110444920/HTMLSTART
- Petignat P, Billieux M, Blouin J, Dahoun S, Vassilakos P. Is genetic analysis useful in the routine management of hydatidiform mole? Hum. Reprod [Internet]. 2003 Feb [cited 2009 Apr 26];18(2):243-249. Available from: http://humrep.oxfordjournals.org/cgi/content/full/18/2/243
- Petignat P, Vassilakos P. Is It Time to Introduce HPV Self-Sampling for Primary Cervical Cancer Screening? Journal of the National Cancer Institute. 2012 Jan 23. Available from: http://jnci.oxfordjournals.org/content/early/2012/01/23/jnci.djr544.long
- Petignat P, Vassilakos P, Campana A. Are fertility drugs a risk factor for persistent trophoblastic tumour? Hum. Reprod [Internet]. 2002 Jun [cited 2009 Apr 26];17(6):1610-1615. Available from: http://humrep.oxfordjournals.org/cgi/content/full/17/6/1610
- Vassilakos P, Petignat P, Boulvain M, Campana A. Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br. J. Cancer [Internet]. 2002 Feb 1 [cited 2009 Apr 26];86(3):382-388. Available from: http://www.nature.com/bjc/journal/v86/n3/abs/6600073a.html
- Anguenot JL, de Marval F, Vassilakos P, Auckenthaler R, Ibéchéole V, Campana A. Combined screening for Chlamydia trachomatis and squamous intra-epithelial lesions using a single liquid-based cervical sample. Hum. Reprod [Internet]. 2001 Oct [cited 2009 Apr 26];16(10):2206-2210. Available from: http://humrep.oxfordjournals.org/cgi/content/full/16/10/2206
- Weintraub J, Bischof P, Tseng L, Redard M, Vassilakos P. CA 125 is an excretory product of human endometrial glands. Biol. Reprod [Internet]. 1990 Apr [cited 2009 Apr 26];42(4):721-726. Available from: http://www.biolreprod.org/cgi/reprint/42/4/721
Other online publications
Abstracts, posters
Links
Edited by Aldo Campana,